Front-line Treatment with Gemcitabine, Paclitaxel, and Doxorubicin for Patients with Unresectable or Metastatic Urothelial Cancer and Poor Renal Function: Final Results from a Phase II Study

Arlene O. Siefker-Radtke, Matthew T. Campbell, Mark F. Munsell, Deborah R. Harris, Robert L. Carolla, Lance C. Pagliaro

Research output: Contribution to journal › Article › peer-review

7 Scopus citations

Fingerprint

Dive into the research topics of 'Front-line Treatment with Gemcitabine, Paclitaxel, and Doxorubicin for Patients with Unresectable or Metastatic Urothelial Cancer and Poor Renal Function: Final Results from a Phase II Study'. Together they form a unique fingerprint.

Medicine & Life Sciences